Papers
1
Total Citations
137
H-Index
1
About
Dr. Lijun Mu is a leading figure in urologic oncology, best known for his transformative work in prostate cancer surgery. His research centers on comparing surgical techniques to optimize patient outcomes, with a particular focus on the benefits of robotic-assisted procedures. His landmark 2018 systematic review and meta-analysis, which has garnered 137 citations, provided compelling evidence that Robot-Assisted Radical Prostatectomy (RARP) offers superior perioperative, functional, and oncologic outcomes compared to both laparoscopic and open approaches. This work has helped establish RARP as a gold standard, directly influencing clinical guidelines and surgical practice worldwide. Dr. Mu’s contributions extend beyond this single study; his body of work systematically evaluates the nuances of minimally invasive surgery, addressing critical questions about recovery, cancer control, and quality of life for prostate cancer patients. By synthesizing complex data into actionable insights, Dr. Mu has not only advanced surgical science but also empowered clinicians and patients to make more informed treatment decisions.
Research Focus
Key Achievements
Top Papers
- 1